Patient Engagement Solutions Market, By Component (Software, Services, and Hardware), By Therapeutic Area, By Delivery Mode, By Application, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Patient Engagement Solutions Market size was valued at US$ 27,650.43 Million in 2024, expanding at a CAGR of 21.10% from 2025 to 2032.
The Patient Engagement Solutions Market focuses on digital tools and platforms designed to enhance interactions between patients and healthcare providers, improve health outcomes, and streamline communication. The rapid growth of telehealth, with over 40% of U.S. adults now using virtual care services, has significantly boosted demand for these solutions. Government initiatives, such as the CMS Interoperability and Patient Access Rule, are encouraging healthcare providers to adopt integrated patient engagement platforms. However, challenges like data security concerns, interoperability issues, and high initial costs—particularly for smaller healthcare facilities—can hinder widespread implementation. Despite these hurdles, emerging technologies such as AI-driven chatbots, mobile health apps, and the growing use of wearable devices—with over 30% of global consumers using them for health monitoring—are driving new market opportunities. Additionally, strategic collaborations between tech companies and healthcare providers are fostering innovation, making patient-centric healthcare more accessible, personalized, and efficient.
Patient Engagement Solutions Market- Market Dynamics
Ø The Impact of Rising Telehealth Adoption and Digital Integration on Patient Engagement Solutions
The rapid growth of telehealth is reshaping patient engagement, with the American Medical Association (AMA) reporting that over 60% of U.S. healthcare providers now utilize virtual care platforms. The World Health Organization (WHO) highlights the critical role of digital health in improving patient adherence, with mobile health apps driving a 40% increase in chronic disease management success rates. Government initiatives, such as the U.S. Health IT for Economic and Clinical Health (HITECH) Act, are accelerating the adoption of secure electronic health records (EHRs) and HIPAA-compliant patient portals, enhancing healthcare accessibility and interoperability.
At the forefront of this transformation, AI-powered chatbots and wearable health devices are revolutionizing real-time patient monitoring. These technologies help reduce hospital readmissions through predictive analytics, enabling proactive care management. As cloud-based platforms streamline healthcare workflows, industry players are heavily investing in AI-driven solutions to further boost patient engagement. This ongoing digital transformation is redefining patient-centered care, making healthcare more accessible, personalized, and efficient on a global scale.
Patient Engagement Solutions Market- Segmentation Analysis:
The Global Patient Engagement Solutions Market is segmented on the basis of Component, Therapeutic Area, Delivery Mode, Application, and Region.
The patient engagement solutions market is divided into three categories based on component: software, services, and hardware. Software leads the market due to the rising adoption of Electronic Health Record (EHR) platforms, patient portals, and AI-driven engagement tools. In 2022, the software segment accounted for the largest share of the global patient engagement solutions market. Services follow, driven by increasing demand for implementation, training, and support. Hardware holds a smaller share, mainly comprising kiosks and wearable health devices.
The market is also divided into four categories based on therapeutic area: chronic diseases, fitness, women\'s health, and mental health. Chronic diseases dominate the market as patient engagement solutions enhance management of conditions like diabetes and cardiovascular diseases. In 2022, the chronic diseases segment accounted for the largest share of the global patient engagement solutions market. Mental health follows, driven by increasing teletherapy adoption. Women\'s health and fitness hold smaller shares, benefiting from mobile health apps and wearable devices.
Patient Engagement Solutions Market- Geographical Insights
The Patient Engagement Solutions Market is witnessing robust global growth, with North America leading due to its advanced healthcare infrastructure, high telehealth adoption, and government initiatives like the HITECH Act, which has driven widespread adoption of digital health solutions. According to the U.S. Centers for Medicare & Medicaid Services (CMS), over 90% of hospitals have adopted certified electronic health records (EHRs), incentivized by programs promoting patient engagement tools. Europe follows closely, supported by stringent regulatory frameworks such as the General Data Protection Regulation (GDPR), which ensures secure digital patient interactions and data privacy. The European Commission’s Digital Health Strategy aims to strengthen digital health adoption across member states, with significant investments in telehealth infrastructure.
The Asia-Pacific region is experiencing rapid growth, driven by countries like China, Japan, and India, which are increasing investments in telemedicine and mobile health applications. For instance, the Chinese government’s Healthy China 2030 initiative aims to expand digital health services nationwide, with telehealth consultations projected to exceed 1 billion annually by 2025. In Latin America, rising internet penetration and government-led digital health initiatives, such as Brazil’s National Telehealth Program, are accelerating market growth. The Middle East & Africa are gradually adopting patient engagement platforms, supported by smart healthcare projects like Saudi Arabia’s Vision 2030, which focuses on digital transformation in healthcare.
Patient Engagement Solutions Market- Competitive Landscape:
The Patient Engagement Solutions Market is highly competitive, with key players focusing on AI-driven platforms, telehealth integration, and secure data management to enhance patient interactions. Industry leaders like Epic Systems, Cerner (Oracle Health), and Allscripts dominate through extensive EHR integration and cloud-based solutions, enabling seamless data exchange and improved care coordination. Companies such as Philips, Medtronic, and GE Healthcare are investing heavily in wearable health technologies and AI-powered analytics to support remote patient monitoring, enhancing real-time health tracking and proactive care. Emerging players like MyChart and Welltok are gaining traction with mobile-based engagement tools designed for personalized healthcare experiences, offering intuitive interfaces and tailored health insights. Strategic collaborations are also reshaping the market, exemplified by Microsoft’s partnership with Nuance to advance AI-driven clinical documentation, streamlining workflows and improving documentation accuracy. Regulatory compliance remains critical, with adherence to standards like HIPAA, GDPR, and HL7 ensuring secure patient data handling and privacy protection. With the growing demand for virtual care, companies are prioritizing scalability, interoperability, and real-time patient engagement, intensifying competition in this rapidly evolving landscape.
Recent Developments:
v February 2025: Smart Meter introduced SmartHealth Solutions at HIMSS 2025—a comprehensive suite of AI-powered tools aimed at enhancing patient engagement. This includes a chronic care management app, gait analysis for remote therapeutic monitoring (RTM), AI-enhanced blood pressure coaching, atrial fibrillation (Afib) monitoring, and an AI avatar designed to improve patient-provider interactions, all focused on improving health outcomes.
v September 2024: PatientPoint launched PatientPoint Focus™ (now rebranded as Precision™), a solution designed for 1:1 patient engagement before, after, and between clinical visits. Utilizing trusted communication channels and consented EHR data, it delivers personalized educational content to empower patients, enabling more effective doctor-patient conversations and encouraging proactive health management.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Ø Allscripts Healthcare Solutions, Inc.
Ø Athenahealth, Inc.
Ø Cerner Corporation
Ø CureMD Healthcare
Ø eClinicalWorks
Ø Epic Systems Corporation
Ø Get Real Health
Ø GetWellNetwork, Inc.
Ø IBM Corporation
Ø Lincor Solutions Ltd.
Ø McKesson Corporation
Ø Medecision, Inc.
Ø Oneview Healthcare PLC
Ø Orion Health Ltd.
Ø WelVU
Ø YourCareUniverse, Inc.
Ø Others
GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032
Ø Software
Ø Services
Ø Hardware
GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032
Ø Chronic Diseases
Ø Fitness
Ø Women\'s Health
Ø Mental Health
Ø Others
GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE- MARKET ANALYSIS, 2019 - 2032
Ø On-Premise
Ø Cloud-Based
GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Ø Health Management
Ø Home Health Management
Ø Social and Behavioral Management
Ø Financial Health Management
GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
Ø North America
o U.S.
o Canada
Ø Europe
o Germany
o UK
o France
o Italy
o Spain
o The Netherlands
o Sweden
o Russia
o Poland
o Rest of Europe
Ø Asia Pacific
o China
o India
o Japan
o South Korea
o Australia
o Indonesia
o Thailand
o Philippines
o Rest of APAC
Ø Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
Ø The Middle East and Africa
o Saudi Arabia
o UAE
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Patient Engagement Solutions Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Patient Engagement Solutions Market Snippet by Component
2.1.2. Patient Engagement Solutions Market Snippet by Therapeutic Area
2.1.3. Patient Engagement Solutions Market Snippet by Delivery Mode
2.1.4. Patient Engagement Solutions Market Snippet by Application
2.1.5. Patient Engagement Solutions Market Snippet by Country
2.1.6. Patient Engagement Solutions Market Snippet by Region
2.2. Competitive Insights
3. Patient Engagement Solutions Key Market Trends
3.1. Patient Engagement Solutions Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Patient Engagement Solutions Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Patient Engagement Solutions Market Opportunities
3.4. Patient Engagement Solutions Market Future Trends
4. Patient Engagement Solutions Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Patient Engagement Solutions Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Patient Engagement Solutions Market Landscape
6.1. Patient Engagement Solutions Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Patient Engagement Solutions Market – By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
7.1.2. Software
7.1.3. Services
7.1.4. Hardware
8. Patient Engagement Solutions Market – By Therapeutic Area
8.1. Overview
8.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
8.1.2. Chronic Diseases
8.1.3. Fitness
8.1.4. Women\'s Health
8.1.5. Mental Health
8.1.6. Others
9. Patient Engagement Solutions Market – By Delivery Mode
9.1. Overview
9.1.1. Segment Share Analysis, By Delivery Mode, 2024 & 2032 (%)
9.1.2. On-Premise
9.1.3. Cloud-Based
10. Patient Engagement Solutions Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Health Management
10.1.3. Home Health Management
10.1.4. Social and Behavioral Management
10.1.5. Financial Health Management
11. Patient Engagement Solutions Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Patient Engagement Solutions Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Patient Engagement Solutions Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Patient Engagement Solutions Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Patient Engagement Solutions Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Patient Engagement Solutions Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Patient Engagement Solutions Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Allscripts Healthcare Solutions, Inc.
12.2.2. Athenahealth, Inc.
12.2.3. Cerner Corporation
12.2.4. CureMD Healthcare
12.2.5. eClinicalWorks
12.2.6. Epic Systems Corporation
12.2.7. Get Real Health
12.2.8. GetWellNetwork, Inc.
12.2.9. IBM Corporation
12.2.10. Lincor Solutions Ltd.
12.2.11. McKesson Corporation
12.2.12. Medecision, Inc.
12.2.13. Oneview Healthcare PLC
12.2.14. Orion Health Ltd.
12.2.15. WelVU
12.2.16. YourCareUniverse, Inc.
12.2.17. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
